Geoff Yarranton

Geoff Yarranton is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as a Science Advisor at ENGEN BIO since November 2015, focusing on research and development consulting. Prior to this role, Geoff Yarranton was the Chief Scientific Officer and Executive Vice President of Research and Development at KaloBios Pharmaceuticals from January 2004 to November 2015, where the focus was on the discovery and development of engineered monoclonal antibodies for human therapy. Additionally, Geoff Yarranton founded and served as CEO of Celscia Therapeutics from January 2003 to January 2004, and previously held the position of Executive Vice President of Research and Development at Coulter Pharmaceuticals from September 1998 to May 2001, concentrating on antibody research and development.